Kenya BioVax Institute reported that locally manufactured vaccines will enter trial production by 2027 as enabling works continue at the Embakasi biotechnology plant. Officials said the first output will include pneumonia vaccines for newborns, produced through platforms aligned with global standards. The project expands Kenya’s biomedical capacity, with the facility expected to deliver six million doses monthly. World Bank partners noted the initiative supports Africa’s broader goal to increase regional pharmaceutical technology and production.

Kenya is advancing a green hydrogen program to improve energy reliability by integrating electrolysis systems powered by Olkaria geothermal steam. KenGen is developing a 100MW hydrogen plant valued at KSh 17 billion to support grid stability and enable clean industrial energy use. The initiative includes producing green ammonia for fertilizer through renewable hydrogen, strengthening local chemical engineering capacity. Experts noted that transmission upgrades remain essential to maximize the technology’s impact on Kenya’s power system.

Kenya reaffirmed plans to accelerate electric mobility during the Africa EV Mobility Show in Nairobi, where officials highlighted ongoing work to deploy 10,000 EV charging stations by 2030. Energy leaders said the draft Kenya Electric Mobility Policy proposes tax reforms to make EVs more affordable. Experts noted that local assembly using completely knocked-down kits offers a practical path to reducing costs, and incentives for partial local manufacturing aim to support industrial growth and expand EV adoption.